Neuroprotective effects of soy phytoestrogens in the rat brain

References

• Kuiper G G, Lemmen J G, Carlsson B, Corton J C, Safe S H, van der Saag P T, van der Burg B, Gustafsson J A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139: 4252–4263
   PubMed Web of Science ®Google Scholar
• Hall J M, Korach K S. Analysis of the molecular mechanisms of human estrogen receptors α and β reveals differential specificity in target promoter regulation by xenoestrogens. J Biol Chem 2002; 277: 44455–444561
   PubMed Web of Science ®Google Scholar
• Patisaul H B, Melby M, Whitten P L, Young L J. Genistein affects ER β- but not ER α-dependent gene expression in the hypothalamus. Endocrinology 2002; 143: 2189–2197
   Google Scholar
• Ise R, Han D, Takahashi Y, Terasaka S, Inoue A, Tanji M, Kiyama R. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 2005; 579: 1732–1740
   PubMed Web of Science ®Google Scholar
• Schreihofer D A. Transcriptional regulation by phytoestrogens in neuronal cell lines. Mol Cell Endocrinol 2005; 231: 13–22
   PubMed Web of Science ®Google Scholar
• Ososki A L, Kennelly E J. Phytoestrogens: a review of the present state of research. Phytother Res 2003; 17: 845–869
   PubMed Web of Science ®Google Scholar
• Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004; 65: 995–1016
   PubMed Web of Science ®Google Scholar
• Dixon R A. Phytoestrogens. Annu Rev Plant Biol 2004; 55: 225–261
   PubMed Web of Science ®Google Scholar
• Cotter A, Cashman K D. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 2003; 61: 346–351
   PubMed Web of Science ®Google Scholar
• Fitzpatrick L A. Soy isoflavones: hope or hype?. Maturitas 2003; 44(Suppl 1)S21–S29
   PubMed Web of Science ®Google Scholar
• Altavilla D, Crisafulli A, Marini H, Esposito M, D'Anna R, Corrado F, Bitto A, Squadrito F. Cardiovascular effects of the phytoestrogen genistein. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 179–186
   PubMedGoogle Scholar
• Kumar N, Allen K, Riccardi D, Kazi A, Heine J. Isoflavones in breast cancer chemoprevention: where do we go from here?. Front Biosci 2004; 9: 2927–2934
   Google Scholar
• McCue P, Shetty K. Health benefits of soy isoflavonoids and strategies for enhancement: a review. Crit Rev Food Sci Nutr 2004; 44: 361–367
   PubMed Web of Science ®Google Scholar
• Messina M, Ho S, Alekel D L. Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 2004; 7: 649–658
   PubMed Web of Science ®Google Scholar
• Valachovicova T, Slivova V, Sliva D. Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem 2004; 4: 881–887
   PubMed Web of Science ®Google Scholar
• Gallagher J C, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause 2004; 11: 290–298
   PubMed Web of Science ®Google Scholar
• Huntley A L, Ernst E. Soy for the treatment of perimenopausal symptoms – a systematic review. Maturitas 2004; 47: 1–9
   Google Scholar
• Krebs E E, Ensrud K E, MacDonald R, Wilt T J. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104: 824–836
   PubMed Web of Science ®Google Scholar
• Pan Y, Anthony M, Clarkson T B. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med 1999; 221: 118–125
   PubMed Web of Science ®Google Scholar
• Lund T D, West T W, Tian L Y, Bu L H, Simmons D L, Setchell K D, Adlercreutz H, Lephart E D. Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci 2001; 2: 20
   PubMed Web of Science ®Google Scholar
• Simon N G, Kaplan J R, Hu S, Register T C, Adams M R. Increased aggressive behavior and decreased affiliative behavior in adult male monkeys after long-term consumption of diets rich in soy protein and isoflavones. Horm Behav 2004; 45: 278–284
   Google Scholar
• Lund T D, Lephart E D. Dietary soy phytoestrogens produce anxiolytic effects in the elevated plus-maze. Brain Res 2001; 913: 180–184
   PubMed Web of Science ®Google Scholar
• Shively C A, Mirkes S J, Lu N Z, Henderson J A, Bethea C L. Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J 2003; 3: 114–121
   Google Scholar
• Lephart E D, Galindo E, Bu L H. Stress (hypothalamic–pituitary–adrenal axis) and pain response in male rats exposed lifelong to high vs. low phytoestrogen diets. Neurosci Lett 2003; 342: 65–68
   PubMed Web of Science ®Google Scholar
• Linford N J, Dorsa D M. 17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002; 67: 1029–1040
   PubMed Web of Science ®Google Scholar
• Ho K P, Li L, Zhao L, Qian Z M. Genistein protects primary cortical neurons from iron-induced lipid peroxidation. Mol Cell Biochem 2003; 247: 219–222
   PubMed Web of Science ®Google Scholar
• Sonee M, Sum T, Wang C, Mukherjee S K. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 2004; 25: 885–891
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen Q, Diaz Brinton R. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med (Maywood) 2002; 227: 509–519
   PubMed Web of Science ®Google Scholar
• Bang O Y, Hong H S, Kim D H, Kim H, Boo J H, Huh K, Mook-Jung I. Neuroprotective effect of genistein against β amyloid-induced neurotoxicity. Neurobiol Dis 2004; 16: 21–28
   PubMed Web of Science ®Google Scholar
• Zeng H, Chen Q, Zhao B. Genistein ameliorates β-amyloid peptide (25–35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 2004; 36: 180–188
   PubMed Web of Science ®Google Scholar
• Linford N J, Yang Y, Cook D G, Dorsa D M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001; 299: 67–75
   PubMed Web of Science ®Google Scholar
• Lee Y B, Lee H J, Won M H, Hwang I K, Kang T C, Lee J Y, Nam S Y, Kim K S, Kim E, Cheon S H, et al. Soy isoflavones improve spatial delayed matching-to-place performance and reduce cholinergic neuron loss in elderly male rats. J Nutr 2004; 134: 1827–1831
   PubMed Web of Science ®Google Scholar
• Trieu V N, Uckun F M. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 1999; 258: 685–688
   PubMed Web of Science ®Google Scholar
• Choi E J, Lee B H. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci 2004; 75: 499–509
   PubMed Web of Science ®Google Scholar
• Buckmaster P S, Dudek F E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol 1997; 385: 385–404
   PubMed Web of Science ®Google Scholar
• Azcoitia I, Sierra A, Garcia-Segura L M. Estradiol prevents kainic acid-induced neuronal loss in the rat dentate gyrus. Neuroreport 1998; 9: 3075–3079
   Google Scholar
• Azcoitia I, Fernandez-Galaz C, Sierra A, Garcia-Segura L M. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J Neurocytol 1999; 28: 699–710
   PubMedGoogle Scholar
• Azcoitia I, Sierra A, Garcia-Segura L M. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J Neurosci Res 1999; 58: 815–822
   PubMed Web of Science ®Google Scholar
• Reibel S, Andre V, Chassagnon S, Andre G, Marescaux C, Nehlig A, Depaulis A. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci Lett 2000; 281: 79–82
   Google Scholar
• Veliskova J, Velisek L, Galanopoulou A S, Sperber E F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 2000; 41(Suppl 6)S30–S35
   Web of Science ®Google Scholar
• Picazo O, Azcoitia I, Garcia-Segura L M. Neuroprotective and neurotoxic effects of estrogens. Brain Res 2003; 990: 20–27
   PubMed Web of Science ®Google Scholar
• Ciriza I, Carrero P, Azcoitia I, Lundeen S G, Garcia-Segura L M. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J Neurobiol 2004; 61: 209–221
   PubMedGoogle Scholar
• Hoffman G E, Moore N, Fiskum G, Murphy A Z. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol 2003; 182: 124–134
   PubMed Web of Science ®Google Scholar
• Hatton W J, von Bartheld C S. Analysis of cell death in the trochlear nucleus of the chick embryo: calibration of the optical disector counting method reveals systematic bias. J Comp Neurol 1999; 409: 169–186
   Google Scholar
• Dubal D B, Zhu H, Yu J, Rau S W, Shughrue P J, Merchenthaler I, Kindy M S, Wise P M. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 2001; 89: 1952–1957
   Google Scholar
• Fitzpatrick J L, Mize A L, Wade C B, Harris J A, Shapiro R A, Dorsa D M. Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J Neurochem 2002; 82: 674–682
   PubMed Web of Science ®Google Scholar
• Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, et al. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA 2003; 100: 9614–9619
   PubMed Web of Science ®Google Scholar
• Carswell H V, Macrae I M, Gallagher L, Harrop E, Horsburgh K J. Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 2004; 287: H1501–H1504
   PubMed Web of Science ®Google Scholar
• D'Astous M, Morissette M, Di Paolo T. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER α agonist. Neuropharmacology 2004; 47: 1180–1188
   Google Scholar
• Zhao L, Wu T W, Brinton R D. Estrogen receptor subtypes α and β contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 2004; 1010: 22–34
   PubMed Web of Science ®Google Scholar
• Azcoitia I, Sierra A, Garcia-Segura L M. Localization of estrogen receptor β-immunoreactivity in astrocytes of the adult rat brain. Glia 1999; 26: 260–267
   PubMed Web of Science ®Google Scholar
• Cardona-Gomez G P, DonCarlos L, Garcia-Segura L M. Insulin-like growth factor I receptors and estrogen receptors colocalize in female rat brain. Neuroscience 2000; 99: 751–760
   PubMed Web of Science ®Google Scholar
• Shughrue P J, Merchenthaler I. Evidence for novel estrogen binding sites in the rat hippocampus. Neuroscience 2000; 99: 605–612
   Google Scholar
• Hart S A, Patton J D, Woolley C S. Quantitative analysis of ER α and GAD colocalization in the hippocampus of the adult female rat. J Comp Neurol 2001; 440: 144–155
   PubMedGoogle Scholar
• Milner T A, McEwen B S, Hayashi S, Li C J, Reagan L P, Alves S E. Ultrastructural evidence that hippocampal α estrogen receptors are located at extranuclear sites. J Comp Neurol 2001; 429: 355–371
   PubMed Web of Science ®Google Scholar
• Garcia-Ovejero D, Veiga S, Garcia-Segura L M, DonCarlos L L. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 2002; 450: 256–271
   PubMed Web of Science ®Google Scholar
• Kalita K, Szymczak S, Kaczmarek L. Non-nuclear estrogen receptor β and α in the hippocampus of male and female rats. Hippocampus 2005; 15: 404–412
   Google Scholar
• Simpkins J W, Yang S H, Liu R, Perez E, Cai Z Y, Covey D F, Green P S. Estrogen-like compounds for ischemic neuroprotection. Stroke 2004; 35(11 Suppl 1)2648–2651
   PubMed Web of Science ®Google Scholar
• Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592–5595
   PubMed Web of Science ®Google Scholar
• Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier J M, Le Pecq J B, Larsen A K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989; 49: 5111–5117
   PubMed Web of Science ®Google Scholar
• Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F, Testolin G. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch Biochem Biophys 2005; 43: 421–427
   Google Scholar
• Sweatt J D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 2001; 76: 1–10
   PubMed Web of Science ®Google Scholar
• Huang R Q, Fang M J, Dillon G H. The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors. Brain Res Mol Brain Res 1999; 67: 177–183
   Google Scholar